Vanadium: Risks and possible benefits in the light of a comprehensive overview of its pharmacotoxicological mechanisms and multi-applications with a summary of further research trends

J Trace Elem Med Biol. 2020 Sep:61:126508. doi: 10.1016/j.jtemb.2020.126508. Epub 2020 Apr 12.

Abstract

Background: Vanadium (V) is an element with a wide range of effects on the mammalian organism. The ability of this metal to form organometallic compounds has contributed to the increase in the number of studies on the multidirectional biological activity of its various organic complexes in view of their application in medicine.

Objective: This review aims at summarizing the current state of knowledge of the pharmacological potential of V and the mechanisms underlying its anti-viral, anti-bacterial, anti-parasitic, anti-fungal, anti-cancer, anti-diabetic, anti-hypercholesterolemic, cardioprotective, and neuroprotective activity as well as the mechanisms of appetite regulation related to the possibility of using this element in the treatment of obesity. The toxicological potential of V and the mechanisms of its toxic action, which have not been sufficiently recognized yet, as well as key information about the essentiality of this metal, its physiological role, and metabolism with certain aspects on the timeline is collected as well. The report also aims to review the use of V in the implantology and industrial sectors emphasizing the human health hazard as well as collect data on the directions of further research on V and its interactions with Mg along with their character.

Results and conclusions: Multidirectional studies on V have shown that further analyses are still required for this element to be used as a metallodrug in the fight against certain life-threatening diseases. Studies on interactions of V with Mg, which showed that both elements are able to modulate the response in an interactive manner are needed as well, as the results of such investigations may help not only in recognizing new markers of V toxicity and clarify the underlying interactive mechanism between them, thus improving the medical application of the metals against modern-age diseases, but also they may help in development of principles of effective protection of humans against environmental/occupational V exposure.

Keywords: 3-HMG-CoA, 3-hydroxy-3-methyl-glutaryl-CoA; AIDS, acquired immune deficiency syndrome; ALB, albumin; ALP, alkaline phosphatase; AS, antioxidant status; Akt, protein kinase B (PKB); AmD, Assoc American Dietetic Association; Anti-B, anti-bacterial; Anti-C, anti-cancer; Anti-D, anti-diabetic; Anti-F, anti-fungal; Anti-O, anti-obesity; Anti-P, anti-parasitic; Anti-V, anti-viral; Anti−HC, anti-hypercholesterolemic; ApoA-I, apolipoprotein A; ApoB, apolipoprotein B; B, bone; BCOV, bis(curcumino)oxavanadyl; BEOV, bis(ethylmaltolato)oxovanadium; BMOV, bis(maltolato)oxavanadium(IV); Bim, Blc-2 interacting mediator of cell death; Biological role; BrOP, bromoperoxidase; C, cholesterol; C/EBPα, CCAAT-enhancer-binding protein α; CD4, CD4 receptor; CH, cerebral hemisphere; CHO-K1, Chinese hamster ovary cells; CXCR-4, CXCR-4 chemokine co-receptor; Cardio-P, cardioprotective; Citrate-T, citrate transporter; CoA, coenzyme A; Cyt c, cytochrome c; DM, diabetes mellitus; ELI, extra low interstitial; ERK, extracellular regulated kinase; FHR, fructose hypertensive rats; FKHR/FKHR1/AFX, class O members of the forkhead transcription factor family; FLIP, FLICE-inhibitory protein; FOXOs, forkhead box class O family member proteins; FPP, farnesyl-pyrophosphate; FasL, Fas ligand, FER: ferritin; GI, gastrointestinal; GLU, glucose; GLUT-4, glucose transporter type 4; GPP, geranyl-pyrophosphate; GPT, glutamate-pyruvate transaminase; GR, glutathione reductase; GSH, reduced glutathione; GSSG, disulfide glutathione; HDL, high-density lipoproteins; HDL-C, HDL cholesterol; HIV, human immunodeficiency virus; HMMF, high molecular mass fraction; HOMA-IR, insulin resistance index; Hb, hemoglobin; HbF, hemoglobin fraction; Hyper-LEP, hyperleptynemia; IDDM, insulin-dependent diabetes mellitus; IGF-IR, insulin-like growth factor receptor; IL, interleukin; INS, insulin; INS-R, insulin resistance; INS-S, insulin sensitivity; IPP, isopentenyl-5-pyrophosphate; IRS, insulin receptor tyrosine kinase substrate; IgG, immunoglobulin G; Industrial importance; Interactions; JAK2, Janus kinase 2; K, kidney; L, liver; L-AA, L-ascorbic acid; LDL, low-density lipoproteins; LDL-C, LDL cholesterol; LEP, leptin; LEP-R, leptin resistance; LEP-S, leptin sensitivity; LEPS, the concentration of leptin in the serum; LMMF, low molecular mass fraction; LPL, lipoprotein lipase; LPO, lipid peroxidation; Lactate-T, lactate transporter; M, mitochondrion; MEK, ERK kinase activator; MRC, mitochondrial respiratory chain; NAC, N-acetylcysteine; NEP, neutral endopeptidase; NIDDM, noninsulin-dependent diabetes mellitus; NO, nitric oxide; NPY, neuropeptide Y; NaVO3, sodium metavanadate; Neuro-P, neuroprotective; OXPHOS, oxidative phosphorylation; Organic-AT, organic anion transporter; Over-W, over-weight; P, plasma; PANC-1, pancreatic ductal adenocarcinoma cells; PARP, poly (ADP-ribose) polymerase; PLGA, (Poly)Lactide-co-Glycolide copolymer; PO43−, phosphate ion; PPARγ, peroxisome-activated receptor γ; PTK, tyrosine protein kinase; PTP, protein tyrosine phosphatase; PTP-1B, protein tyrosine phosphatase 1B; Pharmacological activity; Pi3K, phosphoinositide 3-kinase (phosphatidylinositol 3-kinase); RBC, erythrocytes; ROS, reactive oxygen species; RT, reverse transcriptase; SARS, severe acute respiratory syndrome; SAcP, acid phosphatase secreted by Leshmania; SC-Ti-6Al-4V, surface-coated Ti-6Al-4V; SHR, spontaneously hypertensive rats; SOD, superoxide dismutase; STAT3, signal transducer/activator of transcription 3; Sa, mean roughness; Sq, root mean square roughness; Sz, ten-point height; TC, total cholesterol; TG, triglycerides; TS, transferrin saturation; Tf, transferrin; TfF, transferrin fraction; TiO2, nHA:Ag-Ti-6Al-4V: titanium oxide-based coating containing hydroxyapatite nanoparticle and silver particles; Top-IB, IB type topoisomerase; Toxicological potential; V, vanadium; V-BrPO, vanadium bromoperoxidase; V-DLC, diamond-like layer with vanadium; V5+/V4+, pentavalent/tetravalent vanadium; VO2+, vanadyl cation; VO2+-FER, vanadyl-ferritin complex; VO4-/VO3-, vanadate anion; VO43-, vanadate ion; VS, vanadyl sulfate; Vanadium; WB, whole blood; ZDF rats, Zucker diabetic fatty rats; ZF rats, Zucker fatty rats; breakD, breakdown; eNOS, endothelial nitric oxide synthase; mo, months; n-HA, nano-hydroxyapatite; pRb, retinoblastoma protein; wk, weeks.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Infective Agents / adverse effects
  • Anti-Infective Agents / pharmacology
  • Anticholesteremic Agents / adverse effects
  • Anticholesteremic Agents / pharmacology
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / pharmacology
  • Cardiotonic Agents / adverse effects
  • Cardiotonic Agents / pharmacology
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / pharmacology
  • Neuroprotective Agents / adverse effects
  • Neuroprotective Agents / pharmacology
  • Organometallic Compounds / adverse effects
  • Organometallic Compounds / pharmacology*
  • Vanadium / adverse effects
  • Vanadium / pharmacology*

Substances

  • Anti-Infective Agents
  • Anticholesteremic Agents
  • Antineoplastic Agents
  • Cardiotonic Agents
  • Hypoglycemic Agents
  • Neuroprotective Agents
  • Organometallic Compounds
  • Vanadium